Skip to content

Blended Depression Therapy: Cognitive Behaviour Therapy Face-to-face and Via Internet

European Comparative Effectiveness Research on Internet-based Depression in Sweden (E-compared) Treatment). A Randomized Controlled Trial Comparing Blended Internet and Face-to-face CBT Against Treatment as Usual

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02449447
Acronym
E-compared
Enrollment
150
Registered
2015-05-20
Start date
2015-02-28
Completion date
2017-06-30
Last updated
2017-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorders

Keywords

Major Depressive Disorder (MDD), Blended treatment, Cognitive behavior Therapy (CBT), Face-to-face, internet-based treatment

Brief summary

To asses the clinical effectiveness of blended cognitive behavior therapy (CBT): face-to-face and internet-based treatment for adults with Major Depressive Disorder (MDD) in primary care compared to treatment as usual.

Detailed description

The study is part of a EU-project. Participants are recruited via regular routes from primary care settings. Following the Mini International Neuropsychiatric Interview (M.I.N.I.) participants will be randomly allocated to either blended treatment for 10 sessions/weeks or to treatment as usual. We will include 150 participants in total.

Interventions

BEHAVIORALCognitive behavioral therapy

CBT based on behavioral activation and cognitive therapy techniques including homework

OTHERTreatment as usual

Treatment as usual in primary care including antidepressants and counselling

Sponsors

European Commission
CollaboratorOTHER
Linkoeping University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* depressive symptoms according to DSM-IV * have access to a computer with internet connection * have good knowledge of the Swedish language

Exclusion criteria

* recent (during last 6 weeks) change in psychiatric medication * presently in any other psychological treatment * severe depression * suicidal ideation

Design outcomes

Primary

MeasureTime frameDescription
Quick Inventory of Depressive Symptomatology Self-Report (QIDSChange from baseline in symptoms of depression. Time Frame: 0, 3, 6 and 12 monthsSymptoms of depression measured by the QIDS. The QIDS is a questionnaire that screens for depressive symptoms and assesses depression severity.

Secondary

MeasureTime frameDescription
Client Satisfaction Questionnaire (CSQ-8)Time Frame: 3 months (post treatment)Patient's satisfaction with the treatment is assessed with Client Satisfaction Questionnaire (CSQ-8)
Credibility and Expectancy Questionnaire (CEQ)Time Frame: 3 months (post treatment)Patients' expectancy of treatment will be assessed with the credibility and expectancy questionnaire (CEQ)
System Usability Scale (SUS)Time Frame: 3 months (post treatment)Satisfaction with the internet platform will be evaluated with the system usability scale (SUS)
EuroQol-5D (EQ-5D-5L)Time Frame: 0, 3, 6 and 12 monthsQuality of life will be assessed with the EQ-5D-5L (EuroQol). The EQ-5D-5L is a self-report questionnaire which measures health related quality of life.
Working Alliance Inventory (WAI-SF)Time Frame: 0 months ( three weeks after started treatment)The therapeutic alliance between therapists and patient will be assessed with the short version of the Working Alliance Inventory (WAI-SF).
Trimbos and iMTA questionnaire on Costs associated with Psychiatric illness (TIC-P)Time Frame: 0, 3, 6 and 12 monthsHealth service uptake and production loss due to illness will be measured with the Trimbos and iMTA Questionnaires on Costs Associated with Psychiatric Illness (TiC-P)
Patient Health Questionnaire (PHQ-9)Time Frame: 0, 3, 6 and 12 monthsThe PHQ-9 is a nine-item mood module that can be used to screen and to diagnose patients with depressive disorders.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026